Patients with CTEPH exhibited capillary rarefaction, cardiomyocyte hypertrophy, fibrosis, and altered metabolic pathways compared to controls.
Observational (n=20)
Does pulmonary endarterectomy improve right ventricular remodeling and circulating metabolic profiles in patients with chronic thromboembolic pulmonary hypertension?
Pulmonary endarterectomy in CTEPH patients is associated with right ventricular reverse remodeling and specific changes in circulating metabolic pathways, highlighting potential biomarkers and mechanisms of RV adaptation.
Background Right ventricular (RV) adaptation to chronic thromboembolic pulmonary hypertension (CTEPH) remains incompletely understood. Precise phenotyping of RV reverse remodeling after pulmonary endarterectomy (PEA) may help identify biomarkers and generate hypotheses for future mechanistic and therapeutic studies on RV. We aimed to assess longitudinal changes in RV imaging, histology, and circulating metabolites following PEA. Methods We conducted a prospective study including 10 patients with CTEPH who were referred for PEA and 10 controls with normal RV function who were referred for aortic surgery. All patients underwent preoperative echocardiography, cardiac magnetic resonance, 18-fluoro-deoxy-glucose positron emission tomography, perioperative RV myocardial biopsies, and mass-spectrometry-based untargeted metabolomic analyses of plasma samples. Imaging and metabolomic studies were repeated at 1 and 6 months after surgery in patients with CTEPH to assess their longitudinal evolution. Results Compared to controls, RV histology of patients with CTEPH demonstrated capillary rarefaction, cardiomyocyte hypertrophy, marked fibrosis, and macrophage infiltration, all of which were significantly associated with RV dysfunction, RV-pulmonary arterial (RV-PA) uncoupling, adverse remodeling, and increased myocardial glucose uptake. Circulating metabolic profiles of patients with CTEPH exhibited pronounced alterations in arginine, lysine, purine, and fatty acid metabolic pathways compared to controls, as assessed both cross-sectionally and longitudinally. These metabolic changes were correlated with both histological and imaging features. Conclusions Multimodality imaging, histology, and metabolomics highlighted longitudinal changes associated with RV reverse remodeling following PEA. Capillary rarefaction, cardiomyocyte hypertrophy, fibrosis, and inflammation were observed in CTEPH patients, consistent with previous experimental studies. Alterations in arginine, lysine, purine, and fatty acid metabolic pathways were associated with RV remodeling and recovery, generating hypotheses regarding potential metabolic biomarkers and mechanisms involved in RV adaptation in CTEPH.
Guimaron et al. (Mon,) conducted a observational in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (n=20). Chronic Thromboembolic Pulmonary Hypertension (CTEPH) vs. Controls with normal RV function was evaluated on Longitudinal changes in RV imaging, histology, and circulating metabolites. Patients with CTEPH exhibited capillary rarefaction, cardiomyocyte hypertrophy, fibrosis, and altered metabolic pathways compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: